01.09.2010 • NewsPotashBHP BillitonChina

China May Probe BHP's Bid for Potash

China may launch an antimonopoly probe into BHP Billiton's $38.6 billion bid for Canada's Potash, the China Business News said on Wednesday, citing a source familiar with the matter.

China will also review the merger case of two Russian potash firms - Uralkali and Silvinit - given the major impact the two deals would have on China, the paper cited the unnamed source as saying.

Government departments and state-owned Sinochem have held meetings recently to review the possible impact the two high profile acquisitions could have on China, which is a major purchaser of fertilizer, and about possible countermeasures, according to the source.

BHP, the Anglo-Australian mining giant, last month launched a hostile takeover bid for Potash, the world's largest fertilizer company. Industry analysts have noted that China, as a big importer of potash, would not like to see further concentration in the market that could affect the price of the key fertilizer. Some have mentioned Chinese companies or the government's sovereign wealth fund as possible counter-bidders.

China's largest fertilizer distributor, Sinofert, said last week it was worried about the impact that a BHP deal would have but would not say if its parent, Sinochem, was planning a rival offer.

On Tuesday, the Canadian province of Saskatchewan, the home of takeover target Potash, said it would have "lots of concerns" about a Chinese sovereign fund or state-owned company buying part or all of the company.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.